Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	calcium ion binding	FAT4 EFCAB6 SYT12 SYT17 PCDHA3 SYT2 NCS1 SYT15 EYS FAT1 FAT2 ACAN KCNIP4 PLCB2 PADI6 UNC13A MASP2	2.70e-07	749	103	17	GO:0005509
GeneOntologyMolecularFunction	calcium-dependent phospholipid binding	SYT12 SYT17 SYT2 SYT15	2.61e-04	60	103	4	GO:0005544
GeneOntologyMolecularFunction	clathrin binding	SYT12 SYT17 SYT2 SYT15	3.15e-04	63	103	4	GO:0030276
GeneOntologyMolecularFunction	cytoskeletal motor activity	MYO6 KIF4A KIF2A MYO16 DYNC1H1	3.65e-04	118	103	5	GO:0003774
GeneOntologyMolecularFunction	phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity	OCRL PIKFYVE	3.90e-04	6	103	2	GO:0043813
GeneOntologyMolecularFunction	vascular endothelial growth factor receptor activity	FLT1 FLT3	5.44e-04	7	103	2	GO:0005021
GeneOntologyMolecularFunction	phosphatidylserine binding	SYT12 SYT17 SYT2 SYT15	5.53e-04	73	103	4	GO:0001786
GeneOntologyMolecularFunction	SNARE binding	SYT12 SYT17 SYT2 SYT15 UNC13A	6.98e-04	136	103	5	GO:0000149
GeneOntologyBiologicalProcess	regulated exocytosis	SYT12 SYT17 RAB11FIP2 SYT2 NCS1 PIKFYVE SYT15 SV2C UNC13A	1.54e-05	291	103	9	GO:0045055
GeneOntologyBiologicalProcess	positive regulation of dendrite extension	SYT17 SYT2 AFDN UNC13A	1.66e-05	31	103	4	GO:1903861
GeneOntologyBiologicalProcess	regulation of dendrite extension	SYT17 SYT2 AFDN UNC13A	2.73e-05	35	103	4	GO:1903859
GeneOntologyBiologicalProcess	vesicle-mediated transport in synapse	SGIP1 SYT12 MYO6 ABCA13 SYT17 SYT2 NCS1 SV2C UNC13A	3.33e-05	321	103	9	GO:0099003
GeneOntologyBiologicalProcess	calcium-ion regulated exocytosis	SYT12 SYT17 SYT2 SYT15 UNC13A	5.66e-05	82	103	5	GO:0017156
GeneOntologyBiologicalProcess	exocytosis	SYT12 SYT17 RAB11FIP2 SYT2 NCS1 PIKFYVE SYT15 KCNQ3 SV2C UNC13A	6.33e-05	434	103	10	GO:0006887
GeneOntologyBiologicalProcess	dendrite extension	SYT17 SYT2 AFDN UNC13A	8.15e-05	46	103	4	GO:0097484
GeneOntologyBiologicalProcess	regulation of epithelium regeneration	EPPK1 SERPINE1	1.47e-04	4	103	2	GO:1905041
GeneOntologyBiologicalProcess	detection of visible light	OPN4 GRK7 EYS CACNA2D4	1.89e-04	57	103	4	GO:0009584
GeneOntologyBiologicalProcess	positive regulation of developmental growth	FLT3 SGIP1 SYT17 SYT2 SERPINE1 AFDN UNC13A	1.93e-04	238	103	7	GO:0048639
GeneOntologyBiologicalProcess	epithelium regeneration	EPPK1 SERPINE1	2.45e-04	5	103	2	GO:1990399
GeneOntologyCellularComponent	secretory vesicle	SYT12 ABCA13 SYT17 SYT2 NCS1 PIKFYVE GGH SYT15 ORM1 ORM2 BRCA2 SERPINE1 SV2C PLCB2 PADI6 UNC13A DYNC1H1	1.05e-04	1246	102	17	GO:0099503
Domain	C2	SYT12 RASA2 SYT17 RAB11FIP2 SYT2 SYT15 SYT15B PLCB2 UNC13A	3.77e-08	131	101	9	PF00168
Domain	C2	SYT12 RASA2 SYT17 RAB11FIP2 SYT2 SYT15 SYT15B PLCB2 UNC13A	5.57e-08	137	101	9	SM00239
Domain	C2	SYT12 RASA2 SYT17 RAB11FIP2 SYT2 SYT15 SYT15B PLCB2 UNC13A	7.59e-08	142	101	9	PS50004
Domain	C2_dom	SYT12 RASA2 SYT17 RAB11FIP2 SYT2 SYT15 SYT15B PLCB2 UNC13A	2.61e-07	164	101	9	IPR000008
Domain	-	SYT12 RASA2 SYT17 RAB11FIP2 SYT2 SYT15B PLCB2 UNC13A	1.40e-06	148	101	8	2.60.40.150
Domain	A1A_glycop	ORM1 ORM2	2.90e-05	2	101	2	IPR001500
Domain	LAM_G_DOMAIN	FAT4 EYS FAT1 FAT2	5.16e-05	38	101	4	PS50025
Domain	Laminin_G_2	FAT4 EYS FAT1 FAT2	6.34e-05	40	101	4	PF02210
Domain	LamG	FAT4 EYS FAT1 FAT2	9.26e-05	44	101	4	SM00282
Domain	Synaptotagmin	SYT12 SYT17 SYT2	1.64e-04	20	101	3	IPR001565
Domain	Laminin_G	FAT4 EYS FAT1 FAT2	2.73e-04	58	101	4	IPR001791
Domain	EGF_CA	FAT4 EYS FAT1 FAT2 MASP2	5.26e-04	122	101	5	SM00179
Domain	EGF-like_Ca-bd_dom	FAT4 EYS FAT1 FAT2 MASP2	5.67e-04	124	101	5	IPR001881
Domain	Tyr_kinase_rcpt_3_CS	FLT1 FLT3	7.94e-04	8	101	2	IPR001824
Domain	AC_N	ADCY4 ADCY3	7.94e-04	8	101	2	IPR032628
Domain	Adcy	ADCY4 ADCY3	7.94e-04	8	101	2	IPR030672
Domain	RECEPTOR_TYR_KIN_III	FLT1 FLT3	7.94e-04	8	101	2	PS00240
Domain	AC_N	ADCY4 ADCY3	7.94e-04	8	101	2	PF16214
Domain	EGF_3	FAT4 ADAM29 EYS FAT1 FAT2 MASP2	1.74e-03	235	101	6	PS50026
Domain	-	FAT4 EYS FAT1 FAT2	1.76e-03	95	101	4	2.60.120.200
Domain	ABC_A	ABCA13 ABCA9	1.84e-03	12	101	2	IPR026082
Domain	EGF_Ca-bd_CS	FAT4 EYS FAT1 MASP2	1.90e-03	97	101	4	IPR018097
Domain	EGF_CA	FAT4 EYS FAT1 MASP2	2.05e-03	99	101	4	PS01187
Domain	ASX_HYDROXYL	FAT4 EYS FAT1 MASP2	2.12e-03	100	101	4	PS00010
Domain	Recoverin	NCS1 KCNIP4	2.17e-03	13	101	2	IPR028846
Domain	EGF-like_dom	FAT4 ADAM29 EYS FAT1 FAT2 MASP2	2.33e-03	249	101	6	IPR000742
Domain	EGF-type_Asp/Asn_hydroxyl_site	FAT4 EYS FAT1 MASP2	2.62e-03	106	101	4	IPR000152
Domain	EGF_1	FAT4 ADAM29 EYS FAT1 FAT2 MASP2	2.63e-03	255	101	6	PS00022
Domain	Cadherin_CS	FAT4 PCDHA3 FAT1 FAT2	2.90e-03	109	101	4	IPR020894
Domain	EGF-like_CS	FAT4 ADAM29 EYS FAT1 FAT2 MASP2	2.95e-03	261	101	6	IPR013032
Domain	EGF_2	FAT4 ADAM29 EYS FAT1 FAT2 MASP2	3.18e-03	265	101	6	PS01186
Domain	CADHERIN_1	FAT4 PCDHA3 FAT1 FAT2	3.31e-03	113	101	4	PS00232
Domain	Cadherin	FAT4 PCDHA3 FAT1 FAT2	3.31e-03	113	101	4	PF00028
Domain	CADHERIN_2	FAT4 PCDHA3 FAT1 FAT2	3.41e-03	114	101	4	PS50268
Domain	-	FAT4 PCDHA3 FAT1 FAT2	3.41e-03	114	101	4	2.60.40.60
Domain	CA	FAT4 PCDHA3 FAT1 FAT2	3.52e-03	115	101	4	SM00112
Domain	Cadherin-like	FAT4 PCDHA3 FAT1 FAT2	3.63e-03	116	101	4	IPR015919
Domain	A/G_cyclase_CS	ADCY4 ADCY3	3.73e-03	17	101	2	IPR018297
Domain	LIPOCALIN	ORM1 ORM2	3.73e-03	17	101	2	PS00213
Domain	Cadherin	FAT4 PCDHA3 FAT1 FAT2	3.86e-03	118	101	4	IPR002126
Domain	Lipocalin	ORM1 ORM2	4.19e-03	18	101	2	IPR002345
Domain	-	ADCY4 ADCY3	4.19e-03	18	101	2	3.30.70.1230
Domain	Nucleotide_cyclase	ADCY4 ADCY3	4.19e-03	18	101	2	IPR029787
Domain	Guanylate_cyc	ADCY4 ADCY3	4.66e-03	19	101	2	PF00211
Domain	GUANYLATE_CYCLASE_2	ADCY4 ADCY3	4.66e-03	19	101	2	PS50125
Domain	A/G_cyclase	ADCY4 ADCY3	4.66e-03	19	101	2	IPR001054
Domain	GUANYLATE_CYCLASE_1	ADCY4 ADCY3	4.66e-03	19	101	2	PS00452
Domain	CYCc	ADCY4 ADCY3	4.66e-03	19	101	2	SM00044
Pubmed	The Cell Adhesion Molecule Necl-4/CADM4 Serves as a Novel Regulator for Contact Inhibition of Cell Movement and Proliferation.	FLT1 PTPN13 AFDN	5.16e-07	6	104	3	25893857
Pubmed	Expression of mouse dchs1, fjx1, and fat-j suggests conservation of the planar cell polarity pathway identified in Drosophila.	FAT4 FAT1 FAT2	9.01e-07	7	104	3	16059920
Pubmed	TTF-2, a new forkhead protein, shows a temporal expression in the developing thyroid which is consistent with a role in controlling the onset of differentiation.	TG ORM1 ORM2	9.01e-07	7	104	3	9214635
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	USP36 FAT4 EFCAB6 MYO6 SENP3 KIF4A OCRL FAT1 PTPN13 AFDN MGA DYNC1H1	3.76e-06	777	104	12	35844135
Pubmed	The rat gene map.	TG ORM1 ORM2	4.21e-06	11	104	3	3416641
Pubmed	British Society of Audiology short papers meeting on experimental studies of hearing and deafness. Cambridge, United Kingdom, 22-23 September 1996. Abstracts.	MYO6 ORM1 ORM2	5.60e-06	12	104	3	9183385
Pubmed	SHLD2/FAM35A co-operates with REV7 to coordinate DNA double-strand break repair pathway choice.	EPPK1 SENP3 KIF2A NUP188 DYNC1H1 ZMYM4	6.24e-06	150	104	6	30154076
Pubmed	Genomic analysis of synaptotagmin genes.	SYT12 SYT2 SYT15	7.27e-06	13	104	3	11543631
Pubmed	Distal promoter regions are responsible for differential regulation of human orosomucoid-1 and -2 gene expression and acute phase responses.	ORM1 ORM2	8.86e-06	2	104	2	24389491
Pubmed	A new strategy for identification of N-glycosylated proteins and unambiguous assignment of their glycosylation sites using HILIC enrichment and partial deglycosylation.	ORM1 ORM2	8.86e-06	2	104	2	15253437
Pubmed	Selective binding of coumarin enantiomers to human alpha1-acid glycoprotein genetic variants.	ORM1 ORM2	8.86e-06	2	104	2	16290938
Pubmed	Retinoids increase alpha-1 acid glycoprotein expression at the transcriptional level through two distinct DR1 retinoic acid responsive elements.	ORM1 ORM2	8.86e-06	2	104	2	15157739
Pubmed	Orosomucoid-1 Arises as a Shared Altered Protein in Two Models of Multiple Sclerosis.	ORM1 ORM2	8.86e-06	2	104	2	37949310
Pubmed	Comparison of alpha-1-acid glycoprotein isoforms from healthy and cancer patients by capillary IEF.	ORM1 ORM2	8.86e-06	2	104	2	17987628
Pubmed	α1-Acid Glycoprotein Enhances the Immunosuppressive and Protumor Functions of Tumor-Associated Macrophages.	ORM1 ORM2	8.86e-06	2	104	2	34210751
Pubmed	Orosomucoid 1 promotes colorectal cancer progression and liver metastasis by affecting PI3K/AKT pathway and inducing macrophage M2 polarization.	ORM1 ORM2	8.86e-06	2	104	2	37640741
Pubmed	An acute phase protein α1-acid glycoprotein mitigates AKI and its progression to CKD through its anti-inflammatory action.	ORM1 ORM2	8.86e-06	2	104	2	33846468
Pubmed	Transcriptome Analysis Uncovers a Growth-Promoting Activity of Orosomucoid-1 on Hepatocytes.	ORM1 ORM2	8.86e-06	2	104	2	28927749
Pubmed	α1-Acid glycoprotein decreases neutrophil migration and increases susceptibility to sepsis in diabetic mice.	ORM1 ORM2	8.86e-06	2	104	2	22415874
Pubmed	Structure of 1 -acid glycoprotein. The complete amino acid sequence, multiple amino acid substitutions, and homology with the immunoglobulins.	ORM1 ORM2	8.86e-06	2	104	2	4711474
Pubmed	Structure and expression of the genes coding for human alpha 1-acid glycoprotein.	ORM1 ORM2	8.86e-06	2	104	2	2822385
Pubmed	Adipocytokine orosomucoid integrates inflammatory and metabolic signals to preserve energy homeostasis by resolving immoderate inflammation.	ORM1 ORM2	8.86e-06	2	104	2	20442402
Pubmed	Distinct modes of endocytotic presynaptic membrane and protein uptake at the calyx of Held terminal of rats and mice.	SYT2 UNC13A	8.86e-06	2	104	2	27154627
Pubmed	Orosomucoid1: Involved in vascular endothelial growth factor-induced blood-brain barrier leakage after ischemic stroke in mouse.	ORM1 ORM2	8.86e-06	2	104	2	25264156
Pubmed	Molecular characterization and acute phase expression of the multiple Mus caroli alpha 1-acid glycoprotein (AGP) genes. Differences in glucocorticoid stimulation and regulatory elements between the rat and mouse AGP genes.	ORM1 ORM2	8.86e-06	2	104	2	2354997
Pubmed	Structural heterogeneity of glycoform of alpha-1 Acid glycoprotein in alcoholic cirrhosis patients.	ORM1 ORM2	8.86e-06	2	104	2	25408356
Pubmed	Nucleotide sequence of the mouse alpha 1-acid glycoprotein gene 1.	ORM1 ORM2	8.86e-06	2	104	2	3676251
Pubmed	Structure and characterisation of a duplicated human alpha 1 acid glycoprotein gene.	ORM1 ORM2	8.86e-06	2	104	2	2970990
Pubmed	The disulfide bonds of alpha1-acid glycoprotein.	ORM1 ORM2	8.86e-06	2	104	2	4603214
Pubmed	Orm2 Deficiency Aggravates High-Fat Diet-Induced Obesity through Gut Microbial Dysbiosis and Intestinal Inflammation.	ORM1 ORM2	8.86e-06	2	104	2	37853937
Pubmed	A mouse gene family associated with a major submaxillary-gland glycoprotein.	ORM1 ORM2	8.86e-06	2	104	2	3977853
Pubmed	Structure and expression of mouse alpha 1-acid glycoprotein gene-3 (AGP-3).	ORM1 ORM2	8.86e-06	2	104	2	1605854
Pubmed	Disruption of the type III adenylyl cyclase gene leads to peripheral and behavioral anosmia in transgenic mice.	ADCY4 ADCY3	8.86e-06	2	104	2	11055432
Pubmed	Analysis of the five glycosylation sites of human alpha 1-acid glycoprotein.	ORM1 ORM2	8.86e-06	2	104	2	1567356
Pubmed	Acute phase protein alpha 1-acid glycoprotein interacts with plasminogen activator inhibitor type 1 and stabilizes its inhibitory activity.	ORM1 SERPINE1	8.86e-06	2	104	2	11418606
Pubmed	Plasma alpha-1-acid glycoprotein as a potential predictive biomarker for non-haematological adverse events of docetaxel in breast cancer patients.	ORM1 ORM2	8.86e-06	2	104	2	28554261
Pubmed	Soluble fms-like tyrosine kinase-1 and angiotensin2 target calcitonin gene-related peptide family peptides in maternal vascular smooth muscle cells in pregnancy†.	FLT1 VPS51	8.86e-06	2	104	2	33624744
Pubmed	Evidence for the existence of multiple alpha 1-acid glycoprotein genes in the mouse.	ORM1 ORM2	8.86e-06	2	104	2	3003086
Pubmed	Genome-wide suppressor screen identifies USP35/USP38 as therapeutic candidates for ciliopathies.	USP38 USP35	8.86e-06	2	104	2	31723061
Pubmed	Interaction of acute-phase-inducible and liver-enriched nuclear factors with the promoter region of the mouse alpha 1-acid glycoprotein gene-1.	ORM1 ORM2	8.86e-06	2	104	2	1371400
Pubmed	Structure of human alpha1-acid glycoprotein and its high-affinity binding site.	ORM1 ORM2	8.86e-06	2	104	2	12480518
Pubmed	Orosomucoid in liver diseases.	ORM1 ORM2	8.86e-06	2	104	2	34963738
Pubmed	Genetic variations of orosomucoid genes associated with serum alpha-1-acid glycoprotein level and the pharmacokinetics of paclitaxel in Japanese cancer patients.	ORM1 ORM2	8.86e-06	2	104	2	21638284
Pubmed	Inhibitory effect of AP-1 complex on 5-aminolevulinate synthase gene expression through sequestration of cAMP-response element protein (CRE)-binding protein (CBP) coactivator.	CREBBP ALAS1	8.86e-06	2	104	2	12433930
Pubmed	The bile acid induced hepatokine orosomucoid suppresses adipocyte differentiation.	ORM1 ORM2	8.86e-06	2	104	2	33168190
Pubmed	Mitigation of non-alcoholic steatohepatitis via recombinant Orosomucoid 2, an acute phase protein modulating the Erk1/2-PPARγ-Cd36 pathway.	ORM1 ORM2	8.86e-06	2	104	2	37355990
Pubmed	Molecular cloning of cDNAs corresponding to two genes of alpha 1-acid glycoprotein and characterization of two alleles of AGP-1 in the mouse.	ORM1 ORM2	8.86e-06	2	104	2	2475311
Pubmed	A synthetic retinoic acid receptor agonist Am80 ameliorates renal fibrosis via inducing the production of alpha-1-acid glycoprotein.	ORM1 ORM2	8.86e-06	2	104	2	32651445
Pubmed	Isoform differentiation of intact AGP from human serum by capillary electrophoresis-mass spectrometry.	ORM1 ORM2	8.86e-06	2	104	2	20617306
Pubmed	alpha 1-Acid glycoprotein binds human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein via N-linked glycans.	ORM1 ORM2	8.86e-06	2	104	2	7795416
Pubmed	A novel role of the chromokinesin Kif4A in DNA damage response.	KIF4A BRCA2	8.86e-06	2	104	2	18604178
Pubmed	Investigation of genetic variants of alpha-1 acid glycoprotein by ultra-performance liquid chromatography-mass spectrometry.	ORM1 ORM2	8.86e-06	2	104	2	19018521
Pubmed	SYT14L, especially its C2 domain, is involved in regulating melanocyte differentiation.	SYT17 SYT2 UNC13A	1.15e-05	15	104	3	23999003
Pubmed	Tuning of Glutamate, But Not GABA, Release by an Intrasynaptic Vesicle APP Domain Whose Function Can Be Modulated by β- or α-Secretase Cleavage.	SYT12 SYT17 SYT2 SV2C	1.22e-05	47	104	4	31235642
Pubmed	Genetic mapping of five mouse genes encoding synaptotagmins.	SYT17 SYT2 ACAN	2.43e-05	19	104	3	8747928
Pubmed	CREB binding to the hypoxia-inducible factor-1 responsive elements in the plasminogen activator inhibitor-1 promoter mediates the glucagon effect.	CREBBP SERPINE1	2.65e-05	3	104	2	17721610
Pubmed	Direct binding of Nur77/NAK-1 to the plasminogen activator inhibitor 1 (PAI-1) promoter regulates TNF alpha -induced PAI-1 expression.	NR4A1 SERPINE1	2.65e-05	3	104	2	12506026
Pubmed	Effect of mannosylated derivatives on HIV-1 infection of macrophages and lymphocytes.	ORM1 ORM2	2.65e-05	3	104	2	9455924
Pubmed	Comparative genomics and diversifying selection of the clustered vertebrate protocadherin genes.	FAT1 FAT2	2.65e-05	3	104	2	15744052
Pubmed	Binding of PAI-1 to endothelial cells stimulated by thymosin beta4 and modulation of their fibrinolytic potential.	ORM1 SERPINE1	2.65e-05	3	104	2	16272158
Pubmed	Mapping of a putative genetic locus determining ethanol intake in the mouse.	ORM1 ORM2	2.65e-05	3	104	2	3676756
Pubmed	Immunoglobulin D enhances the release of tumor necrosis factor-alpha, and interleukin-1 beta as well as interleukin-1 receptor antagonist from human mononuclear cells.	ORM1 ORM2	2.65e-05	3	104	2	8774350
Pubmed	Mouse alpha-1-microglobulin/bikunin precursor: cDNA analysis, gene evolution and physical assignment of the gene next to the orosomucoid locus.	ORM1 ORM2	2.65e-05	3	104	2	7689339
Pubmed	Differential interactions and structural stability of chitosan oligomers with human serum albumin and α-1-glycoprotein.	ORM1 ORM2	2.65e-05	3	104	2	24359035
Pubmed	Protection by alpha 1-acid glycoprotein against tumor necrosis factor-induced lethality.	ORM1 ORM2	2.65e-05	3	104	2	7931089
Pubmed	Dexamethasone regulation of alpha 1-acid glycoprotein and other acute phase reactants in rat liver and hepatoma cells.	ORM1 ORM2	2.65e-05	3	104	2	6184374
Pubmed	Human alpha1-acid glycoprotein binds to CCR5 expressed on the plasma membrane of human primary macrophages.	ORM1 ORM2	2.65e-05	3	104	2	11336643
Pubmed	Fatigue-induced Orosomucoid 1 Acts on C-C Chemokine Receptor Type 5 to Enhance Muscle Endurance.	ORM1 ORM2	2.65e-05	3	104	2	26740279
Pubmed	Identification of a new acute phase protein.	ORM1 ORM2	2.65e-05	3	104	2	7545679
Pubmed	The genetic control of sialadenitis versus arthritis in a NOD.QxB10.Q F2 cross.	ORM1 ORM2	2.65e-05	3	104	2	11782015
Pubmed	Acute myeloid leukemia with NUP98-HOXC13 fusion and FLT3 internal tandem duplication mutation: case report and literature review.	FLT3 HOXC13	2.65e-05	3	104	2	19665070
Pubmed	A meta-analysis of genome-wide association studies identifies ORM1 as a novel gene controlling thrombin generation potential.	ORM1 MYBPC3	2.65e-05	3	104	2	24357727
Pubmed	The hepatic orosomucoid/α1-acid glycoprotein gene cluster is regulated by the nuclear bile acid receptor FXR.	ORM1 ORM2	2.65e-05	3	104	2	23861371
Pubmed	Differential expression of the mouse alpha 1-acid glycoprotein genes (AGP-1 and AGP-2) during inflammation and aging.	ORM1 ORM2	2.65e-05	3	104	2	2054382
Pubmed	Phosphoproteome analysis of the human mitotic spindle.	USP36 NEPRO EPPK1 SENP3 KIF4A KIF2A	4.19e-05	210	104	6	16565220
Pubmed	Cloning and enzymatic analysis of 22 novel human ubiquitin-specific proteases.	USP36 USP38 USP35	4.40e-05	23	104	3	14715245
Pubmed	Transcriptional induction of the alpha-1 acid glycoprotein (AGP) gene by synergistic interaction of two alternative activator forms of AGP/enhancer-binding protein (C/EBP beta) and NF-kappaB or Nopp140.	ORM1 ORM2	5.29e-05	4	104	2	8754826
Pubmed	EID3 is a novel EID family member and an inhibitor of CBP-dependent co-activation.	EID3 CREBBP	5.29e-05	4	104	2	15987788
Pubmed	α(1)-Acid glycoprotein up-regulates CD163 via TLR4/CD14 protein pathway: possible protection against hemolysis-induced oxidative stress.	ORM1 ORM2	5.29e-05	4	104	2	22807450
Pubmed	The Acute-Phase Protein Orosomucoid Regulates Food Intake and Energy Homeostasis via Leptin Receptor Signaling Pathway.	ORM1 ORM2	5.29e-05	4	104	2	27207522
Pubmed	TGF-beta-like transcriptional effects of thyroglobulin (Tg) in mouse mesangial cells.	TG SERPINE1	5.29e-05	4	104	2	17495424
Pubmed	CBP-mediated post-translational N-glycosylation of BRCA2.	CREBBP BRCA2	5.29e-05	4	104	2	19578754
Pubmed	Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.	USP36 CREBBP BRCA2 KIF2A MGA ZMYM4	5.70e-05	222	104	6	37071664
Pubmed	Interactome Analysis Reveals Regulator of G Protein Signaling 14 (RGS14) is a Novel Calcium/Calmodulin (Ca2+/CaM) and CaM Kinase II (CaMKII) Binding Partner.	MYO6 RAB11FIP2 SYT2 TG SV2C UNC13A	7.44e-05	233	104	6	29518331
Pubmed	Discovery and Characterization of ZUFSP/ZUP1, a Distinct Deubiquitinase Class Important for Genome Stability.	USP36 USP38 DEPDC5 USP35 VPS51	8.28e-05	147	104	5	29576527
Pubmed	Proteome-wide characterization of N-glycosylation events by diagonal chromatography.	ORM1 ORM2 AFM MASP2	8.63e-05	77	104	4	16944957
Pubmed	Regulation of survivin protein stability by USP35 is evolutionarily conserved.	USP38 USP35	8.80e-05	5	104	2	34438346
Pubmed	Competition between Ski and CREB-binding protein for binding to Smad proteins in transforming growth factor-beta signaling.	SKI CREBBP	8.80e-05	5	104	2	17283070
Pubmed	Homozygous frameshift mutations in FAT1 cause a syndrome characterized by colobomatous-microphthalmia, ptosis, nephropathy and syndactyly.	FAT4 FAT1	8.80e-05	5	104	2	30862798
Pubmed	The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription.	SKI CREBBP	8.80e-05	5	104	2	10823891
Pubmed	Mammalian adenylyl cyclase family members are randomly located on different chromosomes.	ADCY4 ADCY3	8.80e-05	5	104	2	7959689
Pubmed	Comparative mapping of mouse chromosome 4 and human chromosome 9: Lv, Orm, and Hxb are closely linked on mouse chromosome 4.	ORM1 ORM2	8.80e-05	5	104	2	1379092
Pubmed	Clinical associations of the genetic variants of CTLA-4, Tg, TSHR, PTPN22, PTPN12 and FCRL3 in patients with Graves' disease.	PTPN22 TG	8.80e-05	5	104	2	19438904
Pubmed	Genomic organization and chromosomal localization of the mouse IKBKAP gene.	ORM1 ORM2	8.80e-05	5	104	2	11722848
Pubmed	HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.	FAT4 PLB1 EPPK1 KIF4A CREBBP BRCA2 SV2C MGA DYNC1H1 ZMYM4	9.03e-05	754	104	10	35906200
Pubmed	Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.	COL6A3 ORM1 ORM2 FAT2 AFM ACAN	1.27e-04	257	104	6	16335952
Pubmed	Orosomucoid 2 maintains hepatic lipid homeostasis through suppression of de novo lipogenesis.	ORM1 ORM2	1.32e-04	6	104	2	36050503
Pubmed	Ubiquitin-specific Protease 36 (USP36) Controls Neuronal Precursor Cell-expressed Developmentally Down-regulated 4-2 (Nedd4-2) Actions over the Neurotrophin Receptor TrkA and Potassium Voltage-gated Channels 7.2/3 (Kv7.2/3).	USP36 KCNQ3	1.32e-04	6	104	2	27445338
Pubmed	Defects in whirlin, a PDZ domain molecule involved in stereocilia elongation, cause deafness in the whirler mouse and families with DFNB31.	ORM1 ORM2	1.32e-04	6	104	2	12833159
Pubmed	International Colloquium on beta-trace. Osaka, Japan, November 17, 1995. Abstracts.	ORM1 ORM2	1.32e-04	6	104	2	8966221
Interaction	FLT3 interactions	FLT3 EPPK1 PCDHA3 BRCA2 SERPINE1 KIF2A NUP188 VPS51 TAF1L DYNC1H1	5.36e-06	318	103	10	int:FLT3
Cytoband	13q12	FLT1 FLT3 SACS	2.21e-05	24	104	3	13q12
GeneFamily	Synaptotagmins	SYT12 SYT17 SYT2 SYT15	7.31e-07	17	78	4	765
GeneFamily	Cadherin related	FAT4 FAT1 FAT2	5.03e-05	17	78	3	24
GeneFamily	Adenylate cyclases\|Deafness associated genes	ADCY4 ADCY3	8.09e-04	10	78	2	53
GeneFamily	ATP binding cassette subfamily A	ABCA13 ABCA9	1.62e-03	14	78	2	805
GeneFamily	Ubiquitin specific peptidases	USP36 USP38 USP35	1.82e-03	56	78	3	366
GeneFamily	Hyalectan proteoglycans\|V-set domain containing\|Sushi domain containing\|C-type lectin domain containing	CSMD3 ACAN MASP2	1.91e-03	57	78	3	1179
GeneFamily	Protein tyrosine phosphatases, non-receptor type	PTPN22 PTPN13	2.69e-03	18	78	2	812
GeneFamily	Lipocalins	ORM1 ORM2	3.00e-03	19	78	2	631
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT4 EFCAB6 ABCA13 CSMD3 GMNC FAT1 MYO16	2.59e-07	184	104	7	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT4 EFCAB6 ABCA13 CSMD3 GMNC FAT1 MYO16	2.59e-07	184	104	7	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT4 EFCAB6 ABCA13 CSMD3 GMNC FAT1 MYO16	2.59e-07	184	104	7	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 FMO2 SGIP1 NR4A1 ADCY3 ABCA9 SERPINE1	4.11e-07	197	104	7	09946ee8dfb15a2a32da06e5b331f3277ee934f4
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FLT3 SYT12 PTPN22 GMNC CACNA2D4 PLCB2	1.33e-06	148	104	6	12fa2c4922f03803006c606b1b16e79441e3bb13
ToppCell	AT1-AT2_cells-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	BNIP5 FMO2 SYT2 TSPAN1 FAT1 MYO16	1.95e-06	158	104	6	3bc51cfd37b289cc3e866b54ce55a298e5eff690
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	BNIP5 ABCA13 KCNV1 KCNQ3 KCNIP4 CSGALNACT1	3.18e-06	172	104	6	0c2d0bb767e5ce089b42ad49e8b303a103de2d5c
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	BNIP5 ABCA13 KCNV1 KCNQ3 KCNIP4 CSGALNACT1	3.18e-06	172	104	6	eeed177a03c116e9815a8e086d24efc9643b16a4
ToppCell	PND03-Epithelial-Epithelial_Airway-Neurosecretory\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FMO2 TSPAN1 KCNV1 GMNC PTPN13 ALAS1	4.27e-06	181	104	6	092a971661b0aa06c1cdf428dbfa7339a26fb678
ToppCell	COVID-19-Endothelial_cells-Arterial_endothelial_cells\|COVID-19 / group, cell type (main and fine annotations)	ADCY4 FLT1 NR4A1 SERPINE1 SV2C CSGALNACT1	4.69e-06	184	104	6	0f19494789f38ab1a420545e15e748ca7eb345c3
ToppCell	Epithelial-alveolar_epithelial_cell_type_1\|World / Lineage, Cell type, age group and donor	MYO6 SYT17 EFR3B AFDN MYO16 SCAI	4.99e-06	186	104	6	09d95daa3387a4814cffaa4b798cc2810c3759d0
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1\|Adult / Lineage, Cell type, age group and donor	FMO2 SYT17 EFR3B AFDN MYO16 SCAI	5.15e-06	187	104	6	77f78aec946bc6bd85c29aee9ca978ce49f853a3
ToppCell	COVID-19-lung-Artery_EC\|lung / Disease (COVID-19 only), tissue and cell type	ADCY4 FAT4 FLT1 NR4A1 SV2C CSGALNACT1	5.31e-06	188	104	6	eecd7482b3c97d7f49993cb17edfab30c61232fc
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_2-D175\|Adult / Lineage, Cell type, age group and donor	EPPK1 ABCA13 ORM1 ORM2 PTPN13 KCNQ3	5.31e-06	188	104	6	ec38def1fdbb34ed9b30244806975bd5a4370164
ToppCell	LV-14._Fibroblast_III\|World / Chamber and Cluster_Paper	USP36 NR4A1 ADCY3 ABCA9 NCS1 FAT1	5.47e-06	189	104	6	3922135d1f6fc768d71ba3b465585fead6ea68a8
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1-D231\|Adult / Lineage, Cell type, age group and donor	FMO2 SYT17 SYT15 EFR3B AFDN SCAI	5.47e-06	189	104	6	5a04cb25f8f0447b2cecdb6c3695029281aca26d
ToppCell	COVID-19-lung-Artery_EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ADCY4 FAT4 FLT1 NR4A1 SV2C CSGALNACT1	5.64e-06	190	104	6	07b675befcd1d0a9c90cb17b5d22323468325d51
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 SGIP1 ADCY3 ACAN SERPINE1 UNC13A	5.81e-06	191	104	6	04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 SGIP1 NR4A1 ADCY3 ABCA9 SERPINE1	6.17e-06	193	104	6	c8c21eee8c6c086dc2faf416669cd4a002870fbe
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 SGIP1 NR4A1 ADCY3 ABCA9 SERPINE1	6.17e-06	193	104	6	5b602b1702283184bd3943c2a6f2290b7c37e407
ToppCell	LV-14._Fibroblast_III\|LV / Chamber and Cluster_Paper	USP36 NR4A1 ADCY3 ABCA9 NCS1 FAT1	6.35e-06	194	104	6	927c26aea0147f7a4b8fb3f192de4de263f1b978
ToppCell	Bronchial-NucSeq-Immune_Myeloid-Dendritic_cell-DC_1\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ZMYND15 FLT3 KIF4A GGH PLCB2 USP35	6.74e-06	196	104	6	53d1f9e9f009d1417a19ca6f9a83ecdf7776ef88
ToppCell	Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_perivascular_immune_recruiting\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	COL6A3 SGIP1 ADCY3 NCS1 SERPINE1 CSGALNACT1	6.94e-06	197	104	6	cfb3dc4b401800e33c82cfc3baee69dbbd16ac8c
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MYO6 NAP1L2 TSPAN1 KCNIP4 ALAS1	2.99e-05	153	104	5	79c4f4ccdc8249c8461075c73491bc3b2d13344a
ToppCell	NS-moderate-d_07-13-Epithelial-FOXN4+\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	CEP128 GMNC SPATA17 BRCA2 CFAP70	3.38e-05	157	104	5	410c9d74a2085179cfb39853cb6d330fa98c9c1b
ToppCell	droplet-Liver-LIVER_NPC-30m-Myeloid-macrophage/monocyte\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	USP36 FLT3 NAP1L2 GGH SACS	3.70e-05	160	104	5	8dae9b0cf90a09acb196223f45a14680102630b2
ToppCell	droplet-Liver-LIVER_NPC-30m-Myeloid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	USP36 FLT3 NAP1L2 NR4A1 GGH	3.70e-05	160	104	5	e9e52532131cdc3fb01e81cfc046e3f670cc8e75
ToppCell	PND03-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FMO2 TSPAN1 GMNC PTPN13 ALAS1	3.81e-05	161	104	5	c4970501c038ed36de447da70eabff020ad78713
ToppCell	PND03-Epithelial-Epithelial_Airway-Neurosecretory-Secretory\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FMO2 TSPAN1 GMNC PTPN13 ALAS1	3.81e-05	161	104	5	41a89a3d99a9bd6039a3d881d1d9dcd18bc07f25
ToppCell	COVID-19-kidney-Technical/muscle_(Imm)\|kidney / Disease (COVID-19 only), tissue and cell type	ADAM29 CSMD3 EYS UNC13A MYO16	4.04e-05	163	104	5	19c28ce16a588a7f4a035c32726f6ccd67702b5b
ToppCell	5'-Adult-Appendix-Hematopoietic-T_cells-Activated_CD8_T\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RASA2 GRK7 PTPN22 MGA KLRD1	4.16e-05	164	104	5	24fdea5113d92b96f56b06dd2449910a3c785e69
ToppCell	droplet-Lung-21m-Hematologic-myeloid-myeloid_dendritic_cell-myeloid_dendritic_type_1\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FLT3 ABCA9 PLCB2 USP35 KLRD1	4.54e-05	167	104	5	9526e2c7673d569d04e0728a2526318e67432e0a
ToppCell	droplet-Heart-nan-24m-Mesenchymal-coronary_vascular_endothelial_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 FAT4 IBTK EFR3B KLRD1	4.54e-05	167	104	5	a35ace2c722936d2a3e1f0826e5b6ec6b1340d2b
ToppCell	5'-Adult-Appendix-Hematopoietic-T_cells-TRGV2_gdT\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RASA2 PTPN22 FAT2 MGA KLRD1	4.80e-05	169	104	5	8caf7996796a2e2716e3855de855c903d6126bf2
ToppCell	droplet-Lung-nan-18m-Lymphocytic-Regulatory_T\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BNIP5 PTPN22 CACNA2D4 PTPN13 AFM	4.94e-05	170	104	5	064786c1f1ad7665358964765910b0ad46d14685
ToppCell	droplet-Lung-nan-21m-Myeloid-Myeloid_Dendritic_Type_1\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT3 ABCA9 PLCB2 USP35 KLRD1	4.94e-05	170	104	5	d72eb77271d61e27a3d247149561c7f45fadb28b
ToppCell	droplet-Lung-nan-18m-Lymphocytic-regulatory_T_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BNIP5 PTPN22 CACNA2D4 PTPN13 AFM	4.94e-05	170	104	5	6725747df336697708b94999b3ebb40f1721da16
ToppCell	normal-na-Lymphocytic_T-T4_em-male\|normal / PBMC cell types (v2) per disease, treatment status, and sex	FAT2 PTPN13 AFDN KIF2A MASP2	5.08e-05	171	104	5	61318a7aaf3bd8bdd28f8a8614ab4fdf2964b3a3
ToppCell	droplet-Lung-18m-Hematologic-lymphocytic-regulatory_T_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	BNIP5 PTPN22 CACNA2D4 PTPN13 AFM	5.08e-05	171	104	5	10492832db8ebc3cf85503c441f33bd94df9458e
ToppCell	droplet-Lung-18m-Hematologic-lymphocytic-regulatory_T_cell-regulatory_T_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	BNIP5 PTPN22 CACNA2D4 PTPN13 AFM	5.08e-05	171	104	5	7c0a1b0676f6749ee710c6bdeca6d6f7fac79b69
ToppCell	droplet-Fat-Scat-21m-Endothelial-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 FLT1 BRCA2 EFR3B AFDN	5.36e-05	173	104	5	f13124b4cf2ac1dc2895f90f5487d6ac681b0ba4
ToppCell	droplet-Lung-nan-21m-Myeloid-Plasmacytoid_Dendritic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT3 CEP128 CACNA2D4 VPS51 KLRD1	5.36e-05	173	104	5	8fb32a9f2dbec16de840d55b4db7e7718f5a2a7a
ToppCell	droplet-Lung-nan-21m-Myeloid-plasmacytoid_dendritic_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT3 CEP128 CACNA2D4 VPS51 KLRD1	5.36e-05	173	104	5	f663571aaae2365660a8b526c355f4bd1a124a74
ToppCell	5'-GW_trimst-2-LymphNode-Endothelial-blood_vessel_EC-Fetal_venous_EC\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ADCY4 FLT1 TG SYT15B SERPINE1	5.51e-05	174	104	5	6b5ff1cc5fe6705f7ea70b5a892dfbf91e32288d
ToppCell	CV-Mild-6\|Mild / Virus stimulation, Condition and Cluster	USP36 SENP3 CREBBP TSPAN1 DEPDC5	5.66e-05	175	104	5	c4d530dbb37942427c9cd0a1533faeb6a3a45381
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 FAT4 SGIP1 SERPINE1 UNC13A	5.82e-05	176	104	5	9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 FAT4 SGIP1 SERPINE1 UNC13A	5.82e-05	176	104	5	3f8274a7ab67f9f8a8923193763a5543cfe4defa
ToppCell	MS-Treg-naive_CD4\|MS / Condition, Cell_class and T cell subcluster	ADCY4 MTMR12 SENP3 SYT2 CEP128	6.47e-05	180	104	5	7ca083616926d98420fa11a6e5ebc981623f79ac
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ADCY4 FAT4 FLT1 FMO2 SYT15	6.64e-05	181	104	5	4d7793026373cbcf04b15c77f95f1025d07d4c00
ToppCell	facs-Marrow-B-cells-18m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA13 KIF4A CEP128 ORM1 ALAS1	6.82e-05	182	104	5	9025178ede571e3808d4657ad4892152f336c9b4
ToppCell	facs-Marrow-B-cells-18m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCA13 KIF4A CEP128 ORM1 ALAS1	6.82e-05	182	104	5	c075756cd4bb484ede1be2bcdb9eac60eab0573a
ToppCell	facs-Aorta-Heart-3m-Myeloid-macrophage\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT3 KIF4A PTPN22 PLCB2 KLRD1	6.82e-05	182	104	5	df26388c0c46d1c4775103c8e802937b4d4e7470
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ADCY4 FAT4 FLT1 FMO2 SYT15	7.00e-05	183	104	5	3427f3cbe6ea81709750e7dd3ff378f03ae65eab
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NR4A1 PTPN13 KCNIP4 ALAS1 CSGALNACT1	7.00e-05	183	104	5	d340ab5a77e8d819a1dfb4ca3e9a4b9bc988923c
ToppCell	facs-Aorta-Heart-3m-Myeloid-leukocyte\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT3 KIF4A PTPN22 PLCB2 KLRD1	7.00e-05	183	104	5	062ec08d66c923f90fee771b1bf8d98bdc7e6c1b
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	COL6A3 SGIP1 SYT17 ADCY3 FAT1	7.18e-05	184	104	5	102b6f621a5b551e622f97b12d787c080b052a72
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1-D122\|Adult / Lineage, Cell type, age group and donor	FMO2 EFR3B AFDN MYO16 SCAI	7.18e-05	184	104	5	561592edc3083fad41b91811151b442207c65dd9
ToppCell	COVID-19-Epithelial_cells-Airway_ciliated\|COVID-19 / group, cell type (main and fine annotations)	EFCAB6 ABCA13 TSPAN1 SPATA17 CFAP70	7.37e-05	185	104	5	18a40f0a338aa398d81384b5159fb80ce8a2020c
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	FLT3 FAT1 ACAN EFR3B MYO16	7.56e-05	186	104	5	948815663c212c4311329d503b5991cbbbff9808
ToppCell	droplet-Lung-nan-18m-Epithelial-Ciliated_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPPK1 FAM227B TSPAN1 SPATA17 CFAP70	7.56e-05	186	104	5	740fd06bcd3b24e6ff2ecf8080f378afc3e95084
ToppCell	droplet-Heart-nan-3m-Endothelial\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 FLT1 MYO6 SACS AFDN	7.56e-05	186	104	5	0ae5fbe9f210cb25092394267e1d3d6ed05627b8
ToppCell	droplet-Lung-nan-18m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EPPK1 FAM227B TSPAN1 SPATA17 CFAP70	7.56e-05	186	104	5	5ab43a298d23238b34e898d11decf0ad81d1b14e
ToppCell	COPD-Epithelial-Ciliated\|COPD / Disease state, Lineage and Cell class	ABCA13 SYT17 TSPAN1 SPATA17 CFAP70	7.75e-05	187	104	5	f0fd0792f6926f705d175f6e6fd480f12c7a3bd4
ToppCell	normal_Lung-Myeloid_cells-pDCs\|normal_Lung / Location, Cell class and cell subclass	FLT3 HIVEP1 EID3 GGH USP35	7.75e-05	187	104	5	d36751372fd40a46441f07735c9c3c5dcb503f24
ToppCell	RA-14._Fibroblast_III\|RA / Chamber and Cluster_Paper	USP36 NR4A1 ADCY3 NCS1 FAT1	8.15e-05	189	104	5	46e9a58aacd79db5a02898a8c7244e1884adcfd1
ToppCell	RA-14._Fibroblast_III\|World / Chamber and Cluster_Paper	USP36 NR4A1 ADCY3 NCS1 FAT1	8.15e-05	189	104	5	b6e12d24d2b0735730bdc625f8318c1c9c2a9b3b
ToppCell	mild-Myeloid-Immature_Neutrophils_1\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	ABCA13 PTPN22 ORM1 ORM2 CSGALNACT1	8.15e-05	189	104	5	94dd5d4d815449feff7ce157fe7f8234f7c81422
ToppCell	COPD-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	EFCAB6 ABCA13 TSPAN1 SPATA17 CFAP70	8.15e-05	189	104	5	3e77883db34722b9ce0a03ea74caefc92dc7feff
ToppCell	MS-CD8-antiviral_CD4\|MS / Condition, Cell_class and T cell subcluster	MTMR12 EID3 NAIP SYT15 USP38	8.35e-05	190	104	5	8c831c4560b8e70f92b4c15644fea39f7f7afcf2
ToppCell	facs-MAT-Fat-18m-Endothelial\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 FLT1 TSPAN1 EFR3B AFDN	8.35e-05	190	104	5	34e56c5e7ea6a8f227dbaefe73cbb8818d18b523
ToppCell	facs-MAT-Fat-18m-Endothelial-nan\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 FLT1 TSPAN1 EFR3B AFDN	8.35e-05	190	104	5	14cdb660ad3aabcf49572173e7628d8b99dcbe6f
ToppCell	Control-Fibroblasts\|Control / group, cell type (main and fine annotations)	COL6A3 FMO2 SGIP1 ABCA9 SERPINE1	8.35e-05	190	104	5	3a42a9b98d954685d38a741f44545898d0e3e9ce
ToppCell	facs-MAT-Fat-18m-Endothelial-endothelial_cell\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 FLT1 TSPAN1 EFR3B AFDN	8.35e-05	190	104	5	9aaa48f3aad813c87a45efdbb67d255c94f6e6a4
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYO6 SYT17 RAB11FIP2 PTPN13 AFDN	8.56e-05	191	104	5	3e828cffa24ded19f591a7ed6c1fe88ad57fdcac
ToppCell	nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	EFCAB6 ABCA13 TSPAN1 SPATA17 CFAP70	8.56e-05	191	104	5	e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f
ToppCell	nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	EFCAB6 ABCA13 TSPAN1 SPATA17 CFAP70	8.56e-05	191	104	5	9d31c8424d35bdc0c27188b68bfd0f731af3600b
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL6A3 FAT4 FMO2 SGIP1 ABCA9	8.56e-05	191	104	5	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	nucseq-Epithelial-Epithelial_Airway\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	EFCAB6 ABCA13 TSPAN1 SPATA17 CFAP70	8.56e-05	191	104	5	1c528f72c9ef3ef3a850b05e4a9715190832270c
ToppCell	facs-Thymus-Epithelium-24m-Endothelial\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 FLT1 FMO2 SYT15 AFDN	8.77e-05	192	104	5	39afea574725ce0c67afdd79facdb34f819a828d
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 FMO2 SYT12 ABCA9 SERPINE1	8.77e-05	192	104	5	f88aba74d6e8c594c32fe2bc095b5da28b4b28e9
ToppCell	LPS-IL1RA+antiTNF-Endothelial\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT4 FLT1 MYO6 AFDN CSGALNACT1	8.77e-05	192	104	5	04f5a2e3dd6beff027b89d66eefdd92036e041af
ToppCell	facs-Thymus-Epithelium-24m-Endothelial-endothelial_cell\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 FLT1 FMO2 SYT15 AFDN	8.77e-05	192	104	5	597db951b1fbc37db22134c3d27d3ec4ceaa85f7
ToppCell	facs-Thymus-Epithelium-24m-Endothelial-endothelial_cell\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADCY4 FLT1 FMO2 SYT15 AFDN	8.77e-05	192	104	5	bc275a9eccb1c7a46fd58b15ca5acdd9f7495842
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT4 FLT1 MYO6 AFDN CSGALNACT1	8.77e-05	192	104	5	c07d7b40b2aa4eb27ac85801c014a656e2fd01dc
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 FMO2 SYT12 ABCA9 SERPINE1	8.77e-05	192	104	5	41a8326cd5bc19ad5041068501bab4c72399222e
ToppCell	control-Myeloid-Immature_Neutrophils_1\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	ABCA13 PTPN22 ORM1 ORM2 CSGALNACT1	8.77e-05	192	104	5	9f12b79d661ef0f57c2c924e8ecc24a46ea996d2
ToppCell	COVID-19-Heart-Fib_+_EC_+_Pericyte\|Heart / Disease (COVID-19 only), tissue and cell type	COL6A3 FLT1 ABCA9 PTPN13 SERPINE1	8.77e-05	192	104	5	60b1312e84f6d6448365a952469c506c00b5fe93
ToppCell	COPD-Epithelial-Ciliated\|World / Disease state, Lineage and Cell class	ABCA13 SYT17 TSPAN1 SPATA17 CFAP70	8.77e-05	192	104	5	eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e
ToppCell	Control-Epithelial-Ciliated\|Epithelial / Disease state, Lineage and Cell class	EFCAB6 ABCA13 TSPAN1 SPATA17 CFAP70	8.99e-05	193	104	5	0e37d454f3735edd936ee9a5f5f516ac3aad400e
ToppCell	LPS-antiTNF-Endothelial-Endothelial\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT4 FLT1 MYO6 AFDN CSGALNACT1	8.99e-05	193	104	5	02f633b016ab19bfa65bfd0cf32f000549a62148
ToppCell	NS-critical-d_0-4-Lymphoid-NK\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	COL6A3 NCS1 USP38 SERPINE1 DYNC1H1	8.99e-05	193	104	5	1b29525c5936d1b779253b8c20f059fa091c6127
ToppCell	LPS-antiTNF-Endothelial\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT4 FLT1 MYO6 AFDN CSGALNACT1	8.99e-05	193	104	5	5122b1ffba42de190061be34ecdc6176f84e56a3
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	COL6A3 FAT4 FMO2 SGIP1 CSMD3	9.21e-05	194	104	5	011e14d9ed1393275f892060e7708ffadcd0767f
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYO6 SYT17 RAB11FIP2 PTPN13 AFDN	9.21e-05	194	104	5	04bfc555743f7d8821439d05ae442d15e9886c59
ToppCell	nucseq-Epithelial-Epithelial_Alveolar\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYO6 PTPN13 KCNQ3 AFDN SCAI	9.21e-05	194	104	5	53f3e49e91b1096f3226010e2de767efb490dfe4
ToppCell	LPS-IL1RA-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT4 FLT1 MYO6 AFDN CSGALNACT1	9.21e-05	194	104	5	43f92b0533e26633dc94cce554045d641ef8fd76
ToppCell	LPS-IL1RA-Endothelial-Endothelial\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FAT4 FLT1 MYO6 AFDN CSGALNACT1	9.21e-05	194	104	5	1d39d968730a7e85b6161c1c8a6bd38afe9bcad7
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar-AT1\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FMO2 SYT17 EFR3B MYO16 SCAI	9.44e-05	195	104	5	a71ba5e4043e2d35a45a2c60a96b087e31832345
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	COL6A3 FMO2 ADCY3 ABCA9 SERPINE1	9.44e-05	195	104	5	cad6563cc51d212554152c727fc2c249c6a07e4d
ToppCell	Tracheal-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_arterial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ADCY4 FLT1 SYT15 SERPINE1 ALAS1	9.44e-05	195	104	5	517af3e6784f02c382df6f5691945eefaa9ec4ae
Drug	14-F	TG ORM1 ORM2	8.67e-07	5	102	3	CID000079736
Drug	FddClUrd	FLT1 ORM1 ORM2	7.19e-06	9	102	3	CID000060708
Drug	carocainide	ORM1 ORM2	1.99e-05	2	102	2	CID000071970
Drug	2,4,4-trimethyl-2-pentanol	ORM1 ORM2	1.99e-05	2	102	2	CID000094740
Drug	norlorcainide	ORM1 ORM2	1.99e-05	2	102	2	CID000162188
Drug	3-phenylindole	ORM1 ORM2	1.99e-05	2	102	2	CID000096502
Drug	Beta-Escin [11072-93-8]; Up 200; 3.2uM; MCF7; HT_HG-U133A	COL6A3 FAT4 NR4A1 CREBBP ACAN A4GNT CSGALNACT1	2.55e-05	192	102	7	6050_UP
Drug	Sulfadiazine [68-35-9]; Down 200; 16uM; MCF7; HT_HG-U133A	MTMR12 HIVEP1 SYT17 RAB11FIP2 PTPN22 SKI TSPAN1	2.91e-05	196	102	7	5523_DN
Drug	Vitexin [3681-93-4]; Up 200; 9.2uM; MCF7; HT_HG-U133A	RAB11FIP2 NR4A1 KCNV1 EFR3B A4GNT KCNQ3 MASP2	3.01e-05	197	102	7	2810_UP
Drug	Orlistat; Down 200; 10uM; MCF7; HT_HG-U133A	NR4A1 SKI CREBBP ACAN AFDN NUP188 MASP2	3.01e-05	197	102	7	6383_DN
Drug	Metampicillin sodium salt [6489-61-8]; Up 200; 10.4uM; MCF7; HT_HG-U133A	USP36 FBXO40 FAT4 ORM1 ACAN A4GNT NUP188	3.11e-05	198	102	7	2286_UP
Drug	rhamnose	ADCY4 ADCY3 TG ORM1 ORM2 CACNA2D4 ACAN CSGALNACT1 KLRD1	3.22e-05	356	102	9	CID000000840
Drug	2,4,4'-trichlorobiphenyl	ZMYND15 COL6A3 FLT1 HIVEP1 ABCA13 MYT1 KIF4A SYT2 CSMD3 SPATA45 ORM1 FAT2 BRCA2 SACS SV2C KCNIP4 PADI6 MASP2	5.09e-05	1411	102	18	ctd:C081766
Drug	didesmethylimipramine	ORM1 ORM2	5.94e-05	3	102	2	CID000159642
Drug	MD 770222	ORM1 ORM2	5.94e-05	3	102	2	CID000129805
Drug	p-hydroxyketorolac	ORM1 ORM2	5.94e-05	3	102	2	CID003082630
Drug	1-decyl-3-(N,N-diethylcarbamoyl)piperidine	ORM1 ORM2	5.94e-05	3	102	2	CID000120652
Drug	4-hydroxytertatolol	ORM1 ORM2	5.94e-05	3	102	2	CID000163871
Drug	ibuprofenyl-CoA	ORM1 ORM2	5.94e-05	3	102	2	CID003081818
Drug	2,4,5,2',5'-pentachlorobiphenyl	ZMYND15 COL6A3 FLT1 HIVEP1 ABCA13 MYT1 KIF4A SYT2 CSMD3 SPATA45 ORM1 FAT2 BRCA2 SACS SV2C KCNIP4 PADI6 MASP2	6.67e-05	1441	102	18	ctd:C009828
Drug	ADP beta S	ADCY4 ADCY3 GGH SERPINE1 PLCB2	7.23e-05	96	102	5	CID005310996
Disease	oral squamous cell carcinoma (is_marker_for)	FLT3 NAIP PTPN13 SERPINE1	6.10e-05	63	99	4	DOID:0050866 (is_marker_for)
Disease	uveal melanoma (is_implicated_in)	BRCA2 SERPINE1	6.66e-05	4	99	2	DOID:6039 (is_implicated_in)
Disease	Muscular Atrophy, Spinal, Type II	NAIP DYNC1H1	6.66e-05	4	99	2	C0393538
Disease	Muscular atrophy, spinal, infantile chronic form	NAIP DYNC1H1	6.66e-05	4	99	2	C2931358
Disease	Juvenile Spinal Muscular Atrophy	NAIP DYNC1H1	6.66e-05	4	99	2	C0152109
Disease	HMN (Hereditary Motor Neuropathy) Proximal Type I	NAIP DYNC1H1	6.66e-05	4	99	2	C0043116
Disease	congenital muscular dystrophy (implicated_via_orthology)	COL6A3 DYNC1H1	1.66e-04	6	99	2	DOID:0050557 (implicated_via_orthology)
Disease	serine protease inhibitor Kazal-type 2 measurement	ORM1 ORM2	1.66e-04	6	99	2	EFO_0802054
Disease	Squamous cell carcinoma of esophagus	FAT4 CREBBP FAT1 FAT2	3.00e-04	95	99	4	C0279626
Disease	Graves' disease (is_implicated_in)	PTPN22 TG SERPINE1	3.07e-04	39	99	3	DOID:12361 (is_implicated_in)
Disease	Colorectal Carcinoma	ABCA13 ADAM29 CSMD3 ABCA9 GGH FAT1 SACS PANK4 ZMYM4	5.98e-04	702	99	9	C0009402
Disease	coagulation factor XA measurement	ORM1 ORM2	6.01e-04	11	99	2	EFO_0020266
Disease	thrombin generation potential measurement	ORM1 MYBPC3	6.01e-04	11	99	2	EFO_0005538
Disease	autoimmune thyroiditis (is_implicated_in)	PTPN22 TG	7.20e-04	12	99	2	DOID:7188 (is_implicated_in)
Disease	acute myeloid leukemia (implicated_via_orthology)	FLT3 CREBBP	7.20e-04	12	99	2	DOID:9119 (implicated_via_orthology)
Disease	coagulation factor X measurement	ORM1 ORM2	8.48e-04	13	99	2	EFO_0020265
Disease	Malformations of Cortical Development	KIF2A DYNC1H1	9.88e-04	14	99	2	C1955869
Disease	Cortical Dysplasia	KIF2A DYNC1H1	9.88e-04	14	99	2	C0431380
Disease	pre-eclampsia (is_marker_for)	FLT1 CREBBP SERPINE1	9.89e-04	58	99	3	DOID:10591 (is_marker_for)
Disease	Graves' disease (is_marker_for)	TG SERPINE1	1.14e-03	15	99	2	DOID:12361 (is_marker_for)
Disease	sexual dimorphism measurement	USP36 ADCY4 EPPK1 RASA2 TUT7 ADCY3 ACAN EFR3B MGA CSGALNACT1 MYBPC3	1.21e-03	1106	99	11	EFO_0021796
Disease	proliferative diabetic retinopathy (is_marker_for)	FLT1 SERPINE1	1.30e-03	16	99	2	DOID:13207 (is_marker_for)
Disease	Pre-Eclampsia	FLT1 SERPINE1	1.30e-03	16	99	2	C0032914
Disease	carcinoma (implicated_via_orthology)	FAT4 FLT1 FLT3	1.32e-03	64	99	3	DOID:305 (implicated_via_orthology)
Disease	congenital heart disease (implicated_via_orthology)	USP36 PLCB2 MYBPC3	1.63e-03	69	99	3	DOID:1682 (implicated_via_orthology)
Disease	epilepsy (implicated_via_orthology)	KIF4A DEPDC5 UNC13A DYNC1H1	2.25e-03	163	99	4	DOID:1826 (implicated_via_orthology)
Disease	response to angiotensin-converting enzyme inhibitor	TG KCNIP4 SCAI	2.32e-03	78	99	3	EFO_0005325
Disease	progression free survival, ovarian serous carcinoma	ABCA13 MGA	2.46e-03	22	99	2	EFO_0004920, EFO_1001516
Disease	serum IgM measurement	SENP3 PTPN22	2.46e-03	22	99	2	EFO_0004993
Disease	hypothyroidism	FLT3 MYT1 PTPN22 CEP128 TG	2.73e-03	284	99	5	EFO_0004705
Disease	FEV/FEC ratio	COL6A3 FLT1 TUT7 FAM227B ADCY3 TG TTC23 ACAN PANK4 MGA MYO16	2.75e-03	1228	99	11	EFO_0004713
Disease	reticulocyte measurement	RASA2 TUT7 SKI ADCY3 PIKFYVE FAT1 SV2C AFDN DEPDC5 CFAP70	2.84e-03	1053	99	10	EFO_0010700
Disease	Rheumatoid Arthritis	PLB1 PTPN22 GGH ACAN	2.85e-03	174	99	4	C0003873
Disease	depressive symptom measurement	HIVEP1 SGIP1 PCDHA3 ALAS1 KIF2A SCAI	3.17e-03	426	99	6	EFO_0007006
Disease	antiphospholipid antibody measurement	SGIP1 MYO16	3.18e-03	25	99	2	EFO_0005200

Protein segments in the cluster

Peptide	Gene	Start	Entry
PKYNESFQFTLSADA	UNC13A	1596	Q9UPW8
PFDPSFDDVAVFKSY	NAIP	656	Q13075
IKFSDSFFQAVPFVA	NAIP	1186	Q13075
SPDSLFTAKFVAYNE	AFDN	1721	P55196
DFAYEIKPLAFSTTF	ADAM29	131	Q9UKF5
SIANNFPDFSYFRTF	C21orf62	191	Q9NYP8
AFPESSYLFNDEFKE	FAM227B	266	Q96M60
FSYVNSFTKRTVAPD	CEP128	1056	Q6ZU80
DTDFYISKSGFAIQF	CSMD3	1506	Q7Z407
TEYAAVPFDSFTLQK	CSGALNACT1	141	Q8TDX6
DPDTFFAKFTFEYSR	AFM	346	P43652
FNDTNYVIAFAPESK	ABCA9	71	Q8IUA7
DVNDNVPTFASKAYF	FAT4	2356	Q6V0I7
EIQATFFYFTPNKTE	ORM2	61	P19652
FFYFTPNKTEDTIFL	ORM2	66	P19652
TYPAFSFLSAIDNVF	A4GNT	101	Q9UNA3
SESFPYRTKALFAFE	CREBBP	1386	Q92793
ALSSFIEKSETPYNF	ABCA13	2041	Q86UQ4
KSSFILDNGEFYFDT	ABCA13	2341	Q86UQ4
FASVPDFKEFYSESN	ADCY4	876	Q8NFM4
VTEDFPKDSFFNFFS	NAP1L2	361	Q9ULW6
KSLSPFFSEEFYFEI	RASA2	81	Q15283
PAKSSTSFDFLELNY	PTPN22	371	Q9Y2R2
PASASFKFEDFQVYG	NR4A1	96	P22736
FSRTFYDAKSVDEFP	DEPDC5	221	O75140
GFVQDKYSASAFNFP	DEPDC5	1481	O75140
PEFTQTAYKAAFDEN	FAT1	461	Q14517
TFYVEAIAFPSAEFS	PADI6	256	Q6TGC4
NAPAFSQSEYTVFVK	PCDHA3	451	Q9Y5H8
FSTKAFNPSEYQAIT	EYS	1516	Q5T1H1
PTKFATFVFNVFDEN	NCS1	61	P62166
FTFPQTEFFAVTAYQ	MGA	226	Q8IWI9
PKSVSTFQYDRFFEK	ALAS1	191	P13196
SDSLYIPIFSTFFFN	MTMR12	481	Q9C0I1
NSKLPDTFDNFYVSA	MYO16	1046	Q9Y6X6
YEIPAVSSSSFFEEF	IBTK	536	Q9P2D0
FYESVVSFPFFRKEQ	KCNQ3	401	O43525
PVDNEYFFDRSSQAF	KCNV1	96	Q6PIU1
SYFEFVIDPNSFSRT	EID3	241	Q8N140
FEDVTVAATNFSFYD	PLXNB3	606	Q9ULL4
NASLDFETSPKYFLS	FAT2	3276	Q9NYQ8
SFVKFANIEEDTPSY	EFR3B	121	Q9Y2G0
ETFKEIYSQFFPQGD	KCNIP4	106	Q6PIL6
FYATSPEKFTFQEAA	ACAN	256	P16112
AFVYQKDSDPEFRFQ	PANK4	166	Q9NVE7
FTQAPVFFTSSLYKQ	OPN4	121	Q9UHM6
NQTFRFDYAFDDSAP	KIF2A	271	O00139
EIFKEHNFSFYPTFQ	FLT3	716	P36888
DQDEPPFKSAYSSFV	PIKFYVE	36	Q9Y2I7
PSFKRFFYEFSDSSL	BNIP5	561	P0C671
SGSQFEFTQFRKPSY	BRCA2	1121	P51587
APNAVKTAFYLAEFF	GGH	261	Q92820
ESFRDPYSAFFKTDA	EFCAB6	741	Q5THR3
FLTNDYFFTDISDTP	CACNA2D4	631	Q7Z3S7
AKYNFTSSFEFNPEG	CFAP70	56	Q5T0N1
KEVYTFASEPNDVFF	COL6A3	2781	P12111
SEPDFVAKFYQAVAA	C14orf119	121	Q9NWQ9
SFPSIFKFFTEASEA	FAM172A	381	Q8WUF8
FASLPNFADFYTEES	ADCY3	926	O60266
SSRAKEFAFYPSFAS	HOXC13	166	P31276
FATQTYNFEPEQFSS	FBXO40	426	Q9UH90
TFRSDYSNEKPFTGF	MASP2	116	O00187
EIQATFFYFTPNKTE	ORM1	61	P02763
FFYFTPNKTEDTIFL	ORM1	66	P02763
SFISNAVAPFFKSYI	DYNC1H1	151	Q14204
YSFSFPFLEDSLVKV	FMO2	331	Q99518
DKSFTYDFVFDPSTE	KIF4A	46	O95239
QPFKDFVTSAFYDKF	GRK7	161	Q8WTQ7
FSEKQFFSEVFFPNI	SACS	2051	Q9NZJ4
EDSENTFSPYQFKTS	PTPN13	266	Q12923
AQTNKFNYTEFTTPD	SERPINE1	226	P05121
SNFPIDKFLTVFYSV	OR4A8	261	P0C604
KPYKFATLATDFSSF	FNDC8	271	Q8TC99
KTLNPYFNESFSFEI	SYT2	331	Q8N9I0
YFNESFSFEIPFEQI	SYT2	336	Q8N9I0
DFQTVLPSFELFSKY	SPATA17	336	Q96L03
NAYSIFFDEKFSIPL	SYT12	211	Q8IV01
INPVYNETFSFKADA	SYT15	341	Q9BQS2
VFDNTDFEPYKFIDS	SV2C	541	Q496J9
RGTIDPFYNESFSFK	SYT17	381	Q9BSW7
PFYNESFSFKVPQEE	SYT17	386	Q9BSW7
STFSQFPDDAVDYKN	GMNC	221	A6NCL1
APSFLASEKVDFSSY	TAF1L	191	Q8IZX4
YFKDFTFPSDITEFL	NEPRO	216	Q6NW34
KFFFDPSARDQVTYQ	EPPK1	1401	P58107
FPSTFSILKEFNSYG	SLC25A53	151	Q5H9E4
SEQESFTVVFQPFFY	PLB1	271	Q6P1J6
LSTEAFFYFESVKEQ	OCRL	281	Q01968
YSYKSFETAVAPNVA	SKI	406	P12755
FPDAYQSFTDTTTKE	SPATA45	51	Q537H7
DTVPEKVHFFNSFFY	SENP3	416	Q9H4L4
LFTAKEVSFSNKPYF	VPS51	466	Q9UID3
PVAAAFTETVNAYFK	SGIP1	561	Q9BQI5
VSNVTSFFPKDTAYV	USP35	906	Q9P2H5
PVYNETFSFKADATE	SYT15B	396	X6R8R1
YNFLFALSFTTPTFD	NUP188	1586	Q5SRE5
PTFSQLYTFLAASFK	SCAI	341	Q8N9R8
DYESTNPFTAKFRAS	RAB11FIP2	401	Q7L804
YHRPEFESFFNKTFV	USP38	71	Q8NB14
NYIQPTKFVSFEFSA	PLCB2	551	Q00722
YSENTDVFKFSIELF	TTC23	126	Q5W5X9
EKNSPVDQSDFFYEF	TUT7	936	Q5VYS8
GFTYSTPAFSEDFFK	FLT1	1181	P17948
YNRFPDAFVTFSSFQ	TG	211	P01266
PFTYTAEVTSETFNK	ZMYND15	376	Q9H091
DSPKSYIFKDSFQFD	HIVEP1	781	P15822
NFRDSSYPFANKESI	ZMYM4	221	Q5VZL5
EFEPASKSFSYQLEA	USP36	41	Q9P275
TDFEDSPYFKENSAF	TSPAN1	156	O60635
LSQYLFPSFETFNTK	KLRD1	136	Q13241
KSVTDYDFAPFLNNS	MYO6	1141	Q9UM54
NYKALDFSEAPSFTQ	MYBPC3	1171	Q14896
SKVTFDYASFDAQVF	MYT1	581	Q01538